The ADITUM BIO MANAGEMENT is a privately held investment adviser that advises $1.9Bn in regulatory assets under management held in 1 SEC fund types across 4 investment strategies. ADITUM BIO MANAGEMENT is a Public/Private Fund Assets increased by 909.87% over the last 5-years.
The Group has been registered with the SEC for 6.86 years and is comprised of 1 filing and 0 relying advisers. They operate out of 2 office locations with their Headquarters at 1111 BROADWAY, SUITE 1300, OAKLAND, CALIFORNIA. The Group has not been subject to regulatory enforcement actions. They are regulated by 1 US and Non-US bodies.
Their $1.9Bn in assets advised are owned by 3 private funds, 11 public funds and BDCs and 0 other accounts. Assets of Investment Companies (IC) clients own $1.12Bn or 59.26% of Total Assets and Pooled Investment Vehicles (Not IC or BDC) own $772.78mn or 40.74% of Total Assets.
The Group's top investment strategies include Early Stage, Multi Strat and FI/Credit - Diverse, representing 40.74%, 35.12% and 14.62% of total assets, respectively.
They advise Mutual Fund fund type.
The Group uses 3 Fund Administrators, 2 Fund Auditors, 0 Prime Brokers, 4 Custodians and 1 Marketers. It does not report a third-party Fund Administrator in 0 private funds with $0 in assets.
The Group does not disclose any type of fee.
ADITUM BIO MANAGEMENT names 0 sub-advisers to 0 different funds advised by the group. The Group has been named as the sub-adviser to 0 funds.